Cargando…
Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center
Background: Galactagogues are substances that promote lactation, although data on their effects on humans remain limited. We investigated the efficacy of Silitidil to increase milk supply and duration of breastfeeding of a specific subgroup of mothers in need of lactation support. Methods: 161 mothe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747006/ https://www.ncbi.nlm.nih.gov/pubmed/35011014 http://dx.doi.org/10.3390/nu14010140 |
_version_ | 1784630726825607168 |
---|---|
author | Karapati, Eleni Sulaj, Alma Krepi, Adamantia Pouliakis, Abraham Iacovidou, Nicoletta Paliatsiou, Stella Sokou, Rozeta Volaki, Paraskevi Boutsikou, Theodora Iliodromiti, Zoi |
author_facet | Karapati, Eleni Sulaj, Alma Krepi, Adamantia Pouliakis, Abraham Iacovidou, Nicoletta Paliatsiou, Stella Sokou, Rozeta Volaki, Paraskevi Boutsikou, Theodora Iliodromiti, Zoi |
author_sort | Karapati, Eleni |
collection | PubMed |
description | Background: Galactagogues are substances that promote lactation, although data on their effects on humans remain limited. We investigated the efficacy of Silitidil to increase milk supply and duration of breastfeeding of a specific subgroup of mothers in need of lactation support. Methods: 161 mothers from November 2018 until January 2021 were the study subjects in this retrospective study; during their hospitalization, due to neonatal or maternal factors that inhibited lactation, they were prescribed galactagogues. Mothers were surveyed by telephone interview via a 13-item questionnaire. Results: 73.91%, were primigravidas, 78.26% gave birth by cesarean section (CS) and 72.05% continued to take galactagogues after hospital discharge. Of the neonates, 24.22% were preterm ≤37 weeks of gestation, and 55.9% had birth weight (BW) between 2500 and 3500 g. With respect to breastfeeding rates, 100% were breastfed during their first week, 98.8% breastfed during the first month, 87% during the first 4 months, dropping to 56.5% at 6 months, 41% at 1 year and 19.3% over 1 year of age. Conclusions: This study demonstrates that administration of a galactagogue containing Silitidil (Piulatte-Humana) improves breastfeeding rates at from 1 until 12 months of life in mothers with low milk supply during their hospital stay. Further studies are needed to generate evidence-based strategies to improve breastfeeding outcomes. |
format | Online Article Text |
id | pubmed-8747006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87470062022-01-11 Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center Karapati, Eleni Sulaj, Alma Krepi, Adamantia Pouliakis, Abraham Iacovidou, Nicoletta Paliatsiou, Stella Sokou, Rozeta Volaki, Paraskevi Boutsikou, Theodora Iliodromiti, Zoi Nutrients Article Background: Galactagogues are substances that promote lactation, although data on their effects on humans remain limited. We investigated the efficacy of Silitidil to increase milk supply and duration of breastfeeding of a specific subgroup of mothers in need of lactation support. Methods: 161 mothers from November 2018 until January 2021 were the study subjects in this retrospective study; during their hospitalization, due to neonatal or maternal factors that inhibited lactation, they were prescribed galactagogues. Mothers were surveyed by telephone interview via a 13-item questionnaire. Results: 73.91%, were primigravidas, 78.26% gave birth by cesarean section (CS) and 72.05% continued to take galactagogues after hospital discharge. Of the neonates, 24.22% were preterm ≤37 weeks of gestation, and 55.9% had birth weight (BW) between 2500 and 3500 g. With respect to breastfeeding rates, 100% were breastfed during their first week, 98.8% breastfed during the first month, 87% during the first 4 months, dropping to 56.5% at 6 months, 41% at 1 year and 19.3% over 1 year of age. Conclusions: This study demonstrates that administration of a galactagogue containing Silitidil (Piulatte-Humana) improves breastfeeding rates at from 1 until 12 months of life in mothers with low milk supply during their hospital stay. Further studies are needed to generate evidence-based strategies to improve breastfeeding outcomes. MDPI 2021-12-29 /pmc/articles/PMC8747006/ /pubmed/35011014 http://dx.doi.org/10.3390/nu14010140 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karapati, Eleni Sulaj, Alma Krepi, Adamantia Pouliakis, Abraham Iacovidou, Nicoletta Paliatsiou, Stella Sokou, Rozeta Volaki, Paraskevi Boutsikou, Theodora Iliodromiti, Zoi Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title | Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title_full | Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title_fullStr | Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title_full_unstemmed | Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title_short | Mothers in Need of Lactation Support May Benefit from Early Postnatal Galactagogue Administration: Experience from a Single Center |
title_sort | mothers in need of lactation support may benefit from early postnatal galactagogue administration: experience from a single center |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747006/ https://www.ncbi.nlm.nih.gov/pubmed/35011014 http://dx.doi.org/10.3390/nu14010140 |
work_keys_str_mv | AT karapatieleni mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT sulajalma mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT krepiadamantia mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT pouliakisabraham mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT iacovidounicoletta mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT paliatsioustella mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT sokourozeta mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT volakiparaskevi mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT boutsikoutheodora mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter AT iliodromitizoi mothersinneedoflactationsupportmaybenefitfromearlypostnatalgalactagogueadministrationexperiencefromasinglecenter |